Source: Annual Congress 2006 - Mechanisms of respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. M. Mercken, G. J. Hageman, J. M. J. Houben, H. J. Moonen, R. Broekhuizen, A. Bast, E. F. M. Wouters, A. M. W. J. Schols (Maastricht, Netherlands). Pulmonary cachexia and the oxidant/antioxidant balance. Eur Respir J 2006; 28: Suppl. 50, 3796

Member's Comments

No comment yet.

Related content which might interest you: Hormonal changes and catabolic/anabolic imbalance in chronic obstructive pulmonary disease and their importance for pulmonary cachexia Source: Eur Respir J 2002; 20: Suppl. 38, 202s Year: 2002 Nutritional rehabilitation: from pulmonary cachexia to sarcoPD Source: Eur Respir J 2009; 33: 949-950 Year: 2009 C-reactive protein and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease with pulmonary arterial hypertension Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension Source: International Congress 2016 – Connective tissue disorders Year: 2016 Impaired oxidant/antioxidant balance and relationships between inflammatory markers and antioxidants in patients with primary lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 86s Year: 2006 Role of oxidative-antioxidative imbalance and thyroid hormones in stable chronic obstructive pulmonary disease Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Leptin in relation to systemic inflammation and regulation of the energy balance Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=56 Year: 2003 Pulmonary hemodynamics and gasometric parameters associated with exercise induced oxygen desaturation in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 3 Year: 2014 The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement Source: Eur Respir J 2005; 26: Suppl. 49, 543s Year: 2005 Possible role of liver disease and respiratory insufficiency in osteopenia in cystic fibrosis patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Pulmonary hemodynamics and lung function in patients with COPD and DPLD Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Th17 inflammation and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 17(R)-resolvinD1 improves MMP-9/TIMP-1 imbalance leading to amelioration of pulmonary fibrosis in mice Source: International Congress 2016 – ILD pathogenesis Year: 2016 Pulmonary function in smoking and systemic inflammation Source: Annual Congress 2009 - Tobacco: from smoke to disease Year: 2009 The evolution of effort tolerance and body composition in patients with idiopathic pulmonary arterial hypertension Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 miR-126; link between angiogenesis and exercise intolerance in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Pulmonary vascular and cardiac impairment in interstitial lung disease Source: Eur Respir Rev 2017; 26: 160128 Year: 2017 Pulmonary haemodynamics during exercise in COPD Source: International Congress 2015 – Clinical relevance of exercise stress testing of the right ventricle pulmonary circulation unit Year: 2015 Metabolic dysfunction associated with redox imbalance in pulmonary hypertension: Effects of the prolonged sildenafil use Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016